Camurus AB (publ) (STO:CAMX)
739.50
-0.50 (-0.07%)
Nov 20, 2026, 5:29 PM CET
Camurus AB Market Cap
Camurus AB has a market cap or net worth of 44.01 billion as of November 20, 2026. It is the 3,825th most valuable company in the world and the 50th biggest in Sweden. Its market cap has increased by 18.98% in one year.
Market Cap
44.01B
Enterprise Value
39.76B
Revenue
2.42B
Global Rank
Country Rank
#50 Sweden
PE Ratio
58.79
ChartMarket Cap Chart
Since December 3, 2015, Camurus AB's market cap has increased from 1.66B to 44.01B, an increase of 2,545.03%. That is a compound annual growth rate of 34.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 44.01B | 19.79% |
| Dec 30, 2025 | 36.74B | 10.34% |
| Dec 30, 2024 | 33.30B | 11.26% |
| Dec 29, 2023 | 29.93B | 113.76% |
| Dec 30, 2022 | 14.00B | 69.32% |
| Dec 30, 2021 | 8.27B | -18.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioArctic AB | 26.67B |
| Egetis Therapeutics AB | 5.17B |
| Hansa Biopharma AB | 4.59B |
| Vicore Pharma Holding AB | 2.77B |
| Saniona AB | 1.55B |
| Genovis AB (publ.) | 1.53B |
| Flerie AB | 1.08B |
| Infant Bacterial Therapeutics AB | 934.92M |